Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Lemoine

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Microorganisms|April 27, 2024
Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster DoseDominique Bertrand, Charlotte Laurent, Mathilde Lemoine, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2021
Kidney Transplant T Cell-Mediated Rejection Occurring After Anti-CD19 CAR T-Cell Therapy for Refractory Aggressive Burkitt-like Lymphoma With 11q Aberration: A Case ReportTristan de Nattes, Vincent Camus, Arnaud François, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 10, 2022
Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipientsDominique Bertrand, Veronique Lemée, Charlotte Laurent, et al.
Clinical Kidney Journal|September 2, 2021
Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patientsDominique Bertrand, Mélanie Hanoy, Stéphane Edet, et al.
Clinical Kidney Journal|December 24, 2021
Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature reviewMaxime Dauvergne, David Buob, Cédric Rafat, et al.
Clinical Transplantation|August 13, 2024
Epstein-Barr Virus-Associated Smooth Muscle Tumor After Kidney Transplantation: A French Multicenter Retrospective StudyLaurène Tardieu, Dany Anglicheau, Rebecca Sberro-Soussan, et al.
Journal of the American Society of Nephrology : JASN|June 11, 2021
Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis PatientsDominique Bertrand, Mouad Hamzaoui, Veronique Lemée, et al.
Annals of Transplantation|June 24, 2025
Kidney Transplant Recipients Switching to Prolonged-Release Tacrolimus: Five-Year Real-World Clinical Outcomes From the CHORUS StudyNassim Kamar, László Kóbori, Mathilde Lemoine, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2022
Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score >2):  a retrospective cohort studyDominique Bertrand, Marie Matignon, Antoine Morel, et al.
Transplantation Direct|November 22, 2021
SARS-CoV-2-specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19Dominique Bertrand, Mouad Hamzaoui, Laurent Drouot, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Microorganisms|April 27, 2024
Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster DoseDominique Bertrand, Charlotte Laurent, Mathilde Lemoine, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2021
Kidney Transplant T Cell-Mediated Rejection Occurring After Anti-CD19 CAR T-Cell Therapy for Refractory Aggressive Burkitt-like Lymphoma With 11q Aberration: A Case ReportTristan de Nattes, Vincent Camus, Arnaud François, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 10, 2022
Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipientsDominique Bertrand, Veronique Lemée, Charlotte Laurent, et al.
Clinical Kidney Journal|September 2, 2021
Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patientsDominique Bertrand, Mélanie Hanoy, Stéphane Edet, et al.
Clinical Kidney Journal|December 24, 2021
Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature reviewMaxime Dauvergne, David Buob, Cédric Rafat, et al.
Clinical Transplantation|August 13, 2024
Epstein-Barr Virus-Associated Smooth Muscle Tumor After Kidney Transplantation: A French Multicenter Retrospective StudyLaurène Tardieu, Dany Anglicheau, Rebecca Sberro-Soussan, et al.
Journal of the American Society of Nephrology : JASN|June 11, 2021
Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis PatientsDominique Bertrand, Mouad Hamzaoui, Veronique Lemée, et al.
Annals of Transplantation|June 24, 2025
Kidney Transplant Recipients Switching to Prolonged-Release Tacrolimus: Five-Year Real-World Clinical Outcomes From the CHORUS StudyNassim Kamar, László Kóbori, Mathilde Lemoine, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2022
Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score >2):  a retrospective cohort studyDominique Bertrand, Marie Matignon, Antoine Morel, et al.
Transplantation Direct|November 22, 2021
SARS-CoV-2-specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19Dominique Bertrand, Mouad Hamzaoui, Laurent Drouot, et al.
Pageof 4